Pharmazeutische Zeitung online Zudem stellte er eine doppelblinde randomisierte Phase-III-Studie vor, in der Palonosetron versus Granisetron (Tag 1), jeweils gefolgt von Aprepitant und Dexametason (ab Tag 2), bei Patienten mit soliden Tumoren unter hoch emetogener Chemotherapie ... and more »
Clinical Oncology News However, he pointed out that guidelines from the National Comprehensive Cancer Network classify anthracycline-based chemotherapy as highly emetogenic and the standard of care is the three-drug combination of aprepitant , a 5-HT 3 receptor antagonist ...
PR Newswire (press release) Development of other Category 3.1 generic drugs in the pipeline such as Levetiracetam injection, Lacosamide, and Aprepitant are also in progress as planned. Including these three drug development projects, the Group has a total of 17 Category 3.1 ...
Pharmacy Practice News The decision was bolstered by a Phase III trial showing that single-dose IV fosaprepitant is noninferior to the multiday oral aprepitant therapy (J Clin Oncol 2011;29:1495-1501). After the cancer hospital started to use the IV regimen (based on the ...